Summary
Centene Corporation (CNC) filed an 8-K on May 15, 2026, detailing the outcomes of its Annual Meeting of Stockholders held on May 12, 2026. The report confirms the election of all nine director nominees for a one-year term, with strong support across the board. Additionally, shareholders provided a non-binding advisory vote of approval for the company's executive compensation and ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Of note, a shareholder proposal requesting an independent board chairman was not approved. The filing also clarifies the company's executive officer positions following recent appointments, with Sarah London continuing as CEO and key leadership roles in Medicaid, Medicare, and other operational areas outlined.
Key Highlights
- 1All nine director nominees were overwhelmingly elected for a one-year term at the Annual Meeting.
- 2Shareholders approved the company's executive compensation in a non-binding advisory vote.
- 3KPMG LLP was ratified as Centene's independent registered public accounting firm for the fiscal year ending December 31, 2026.
- 4A shareholder proposal advocating for an independent board chairman was defeated.
- 5The report clarifies the current executive officer team, including recent appointments for Group President roles in Medicaid/Marketplace and Medicare/Specialty.
- 6A significant majority of common stock was represented at the Annual Meeting (412,968,059 shares).